AI-driven cardiology company Ultromics has raised $55 million in a Series C funding round led by L&G, Allegis Capital, and Lightrock. Additional participants included Oxford Science Enterprises, GV, Blue Venture Fund, Oxford University, UCM Ventures (affiliated with UChicago Medicine), and UPMC Enterprises. The funding positions Ultromics for nationwide expansion across the U.S. healthcare market. Addressing